Isomorphic Labs
✓ Verified
Healthcare AI
AI drug discovery
Series B
Isomorphic Labs is an Alphabet-owned AI-first drug discovery company that uses machine learning and predictive/generative models to reimagine the drug discovery process, with a focus on designing novel molecules and accelerating the development of new medicines. The company was launched from DeepMind and builds on the AlphaFold system, aiming to apply AI across multiple therapeutic areas and drug modalities.
Company Details
- Website
- isomorphiclabs.com
- Headquarters
- London, England, United Kingdom
- Founded
- 2021
- Funding
- $2.7B
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring